elotuzumab
abbvie,bms
['mmsm', 'elotuzumab']
congress #asco22 | samer ali srour presents a phase ii study of umbilical cord blood derived nk cells with elotuzumab, lenalidomide, and high-dose melphalan followed by asct in patients with high-risk #mm.
n=30. 2-year pfs and os rates were 83% and 97%.
#mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma